Midgard Science

Labs / Assays & in vitro testing

AvenCell

Dresden, Germany · avencell.com

On your own

Free. Their own form.

Contact AvenCell directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

AvenCell is a clinical-stage biopharmaceutical company developing next-generation immunotherapies for hard-to-treat cancers. It focuses on engineered T-cell therapies, with operations in Watertown, Massachusetts, and offices in Dresden, Germany and Tokyo, Japan.

They take quote requests by email.

What they offer

  • Universal Switchable CAR platform

    Develops switchable CAR-T cell therapies designed for controllable targeting of cancer antigens using soluble targeting modules.

  • Allogeneic platform

    Develops allogeneic, switchable CAR-T cell products engineered to address limitations of current gene-edited allogeneic T-cell therapies.

  • Clinical-stage immunotherapy development

    Advances autologous and allogeneic universal reprogrammable T-cell products focused initially on hard-to-treat cancers.

  • Clinical and strategic collaborations

    Collaborates with partners on joint development of novel immunotherapies based on its platform technologies.

What they work on

Modalities
Antibody, Cell therapy, Gene editing
Therapeutic areas
hard-to-treat cancers, solid tumors, oncology
Sites
Watertown, MA, USA · Dresden, Germany · Tokyo, Japan
Address
500 Forge Road Watertown, MA 02472 USA

Public records

GLP
In compliance · BfR source
BfR GLP site
AvenCell Europe GmbH, Dresden, DE source

Similar labs. CDI Labs, Minaris, PROGEN INC, 3C Therapeutics

Found in a contract services directory, the German GLP list (BfR). Listing built from avencell.com. Work here? Claim this listing.

AvenCell · Midgard Science